Skip to content

Role of Serum Lactate and Base Excess as early markers in screening of newborn infections

Role of Serum Lactate and Base Excess as early markers in screening of neonatal sepsis-A prospective observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/108544
Enrollment
70
Registered
2026-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P369- Bacterial sepsis of newborn, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Aditya Kotturu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Antenatal risk factors for sepsis Foul smelling liquor PROM more than 18hrs Leak PV Chorioamnionitis Prepartum fever 2. With clinical features of sepsis: Hypothermia or fever. Lethargy, refusal of feeds Hypotonia Bradycardia or tachycardia Respiratory distress Hypotension or shock

Exclusion criteria

Exclusion criteria: 1. Neonate with proven blood culture sepsis before admission 2. Neonates with major congenital anomaly. 3. Neonates with birth asphyxia. 4. Neonates started on prior antibiotics before admission 5. Refusal to give consent

Design outcomes

Primary

MeasureTime frame
To estimate the combined role of lactate (arterial or venous) at 6, 12 and 24 hours of life, base excess at 6, 12 and 24 hours of life, blood culture after 48 hours of life and sepsis screen at 6 hours of life, sepsis screen will be repeated at 12 and 24 hours depending on clinical condition of the baby and assessedTimepoint: To estimate the combined role of lactate (arterial or venous) at 6, 12 and 24 hours of life, base excess at 6, 12 and 24 hours of life, blood culture after 48 hours of life and sepsis screen at 6 hours of life, sepsis screen will be repeated at 12 and 24 hours depending on clinical condition of the baby and assessed

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Rohith H R

BGS Global Institute of Medical Sciences

drrohith234@gmail.com9035020302

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026